Phase 1 Acute Lymphoblastic Leukemia ALL Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.

Lymphoblastic LymphomaAcute Lymphoblastic Leukemia ALL

Allterum Therapeutics, Inc24 enrolled4 locationsNCT07586618

Recruiting

Phase 1

CAR T Cells in the Treatment of Refractory and Relapsed CD19+ B Cell Neoplasms

Acute Lymphoblastic Leukemia ALLLarge B-cell LymphomaMantle Cell Lymphoma (MCL)

FamiCordTx6 enrolled2 locationsNCT06593145